... reliable genetic tests to guide lung cancer treatment has taken a step forward. Researchers ... genetic profiles, or signatures, to predict the likelihood that cancer would recur in patients whose non- ...
BOSTON, July 8 (UPI) -- U.S. medical scientists say they've found circulating tumor cells reveal genetic signatures of dangerous lung cancers, possibly leading to targeted therapy.
OSAKA, Japan, Aug. 12 (UPI) -- A Japanese-led study suggests an experimental combination of chemotherapy agents might be a good alternative to standard lung cancer treatment.
... ever study to examine the benefits of customizing lung cancer treatment based on mutations in the epidermal growth ... deletion.
"Therefore non-small-cell lung cancers with EGFR mutations display a two- ...
... -small-cell lung cancer is chemotherapy and radiation therapy. Unfortunately, these aggressive treatments can put ... rather than photons to kill fast growing cancer cells.
"Because proton therapy allows ...
... solid tumor. Non–small cell lung cancer (NSCLC) constitutes over 75 percent of ... regulation of inorganic phosphates has a place in lung cancer treatment, and our eventual goal is to collect sufficient ...
PHILADELPHIA, March 9 (UPI) -- U.S. radiologists say they have developed a new lung cancer treatment that avoids conventional radiation regimens or surgical procedures.
... been treated for stage III non-small cell lung cancer at U-M and the VA Ann Arbor.
The ... at using PET imaging during the course of lung cancer treatment to personalize high dose radiation therapy in ...
... 83,101 patients 65 years old or older who were diagnosed with non-small cell lung ... greater disparities in receiving treatment.
The study indicates that lung cancer treatment disparities were just as ...
... -dimensional conformal radiotherapy (3D-CRT) with dose-per-fraction escalation for treatment of stage III non-small-cell lung cancer (Poland) Confirmation that EGFR mutations ( ...
A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, ... inhibition of apoptosis, further setting the stage for cancer.
Patrizia Russo, Ph.D. and Laura ...
... standard of care for early-stage lung cancer treatment in patients with co-existing medical ... great precision.
"Despite the high potency of the treatment, less than 20 percent of these extremely frail ...
Stereotactic body radiation therapy should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to ...
... trial that demonstrates the power of personalized medicine in lung cancer treatment,” says Lecia Sequist, MD, MPH, of the MGH Cancer Center, who led the study. “It is an exciting glimpse into ...
... … Mouse embryonic stem cells build a heart … New use possible for ethanol plant wastes … Microchip to aid lung cancer treatments ... Health/Science news from UPI.
